U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07004153) titled 'A Study of DIA:CONN P8 Smart Insulin Pen With CGM-Based Coaching in Patients With Type 1 or Type 2 Diabetes' on May 27.
Brief Summary: A Study of DIA:CONN P8 Smart Insulin Pen With CGM-Based Coaching in Patients With Type 1 or Type 2 Diabetes
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus
Intervention:
DEVICE: Smart Coaching Insulin Pen
Subjects randomized to the intervention group will use the DIA:CONN P8 smart insulin pen with full functionality, including Setup Wizard, CGM-based insulin injection coaching, and a bolus calculator. During the 12-week application period, including the base...